Asthma Trial, Recruiting (NCT06612294)

Asthma Trial, Recruiting NCT06612294 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT06612294 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are older than 60 years of age
You speak English or Spanish
You have been told by a doctor that you have asthma, or you believe you have asthma, and this has been the case for more than 1 year
Your asthma is currently not well controlled

Who may not be able to join:

You have been diagnosed with dementia
You have a long-term lung condition such as COPD (chronic obstructive pulmonary disease) or another ongoing breathing illness
You have a serious heart condition called congestive heart failure that is at an advanced stage (confirm with trial site)
You have a significant history of cigarette smoking — specifically, more than 15 "pack-years," which is a measure of how much and how long you have smoked (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06612294

Sponsor: Icahn School of Medicine at Mount Sinai

Phase: Not Applicable

Status: Recruiting

Condition: Asthma

More information: https://clinicaltrials.gov/study/NCT06612294

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are older than 60 years of age
You speak English or Spanish
You have been told by a doctor that you have asthma, or you believe you have asthma, and this has been the case for more than 1 year
Your asthma is currently not well controlled

Who may not be able to join:

You have been diagnosed with dementia
You have a long-term lung condition such as COPD (chronic obstructive pulmonary disease) or another ongoing breathing illness
You have a serious heart condition called congestive heart failure that is at an advanced stage (confirm with trial site)
You have a significant history of cigarette smoking — specifically, more than 15 "pack-years," which is a measure of how much and how long you have smoked (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Icahn School of Medicine at Mount Sinai

Registry

ClinicalTrials.gov

Start date

18 September 2024

Est. completion

22 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peak expiratory flow (PEF) Values; Mean daily ICS dose used

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov